Digital health company Everlywell reported on Wednesday the launch of the Everlywell COVID-19 Test Home Collection Kit DTC for broad use without a prescription, including purchase by asymptomatic individuals, retailers, pharmacies as well as organizations.

Following US Food and Drug Administration's (FDA) Emergency Use Authorization (EUA), the Everlywell COVID-19 Test Home Collection Kit DTC is now available without a doctor's prescription directly to individuals who are not experiencing symptoms and who have no suspected exposure to COVID-19. The unit is now authorized for sale directly to consumers online and on shelves at retailers.

The Everlywell COVID-19 Test Home Collection Kit DTC is an FDA-authorized mail-in home collection test kit for COVID-19 suitable for adults 18 years and older in all 50 US states. The Kit is processed using gold-standard rt-PCR technology to identify the presence or absence of the virus that causes COVID-19 in both symptomatic and asymptomatic individuals.

Adults 18 years and older can now purchase the Everlywell COVID-19 Test Home Collection Kit DTC in quantities up to 99. Retailers interested in carrying US FDA-authorized, diagnostic (PCR) COVID-19 Test Home Collection Kits on shelves or online can contact retail everlywell.com. Organizations looking to test 100 or more participants can leverage several COVID-19 testing options, including PCR and rapid antigen tests, with the company's digital platform to manage the logistics of test distribution and seamless digital results reporting.